$1,650.00
We use our efficient, integration-free, small-molecule-based method to differentiate high-quality astrocytes from human iPSCs. The differentiated astrocytes recapitulate the phenotype and functional parameters of primary and in vivo astrocytes.
We provide astrocytes differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from the fibroblasts of an African American male donor. These high-purity (>95%) cells express high levels of astrocyte biomarkers GFAP and s100beta
These iPSC-differentiated astrocytes can be used as control lines to compare the phenotype and functionality of patient-derived, genome-edited iPSC-derived astrocytes for drug screening applications. These astrocytes can also be used in neurotoxicity assays.
| Table Header | Table Header |
|---|---|
|
Age |
Neonate |
|
Gender |
Male |
|
Ethnicity |
African American |
|
Tissue source |
Dermal fibroblasts |
|
Reprogramming method |
Episomal |
|
Culture conditions |
Feeder-free |
